X

Investor News: Investigation over potential Wrongdoing at Heron Therapeutics Inc (NASDAQ:HRTX)

An investigation for investors in NASDAQ:HRTX shares was announced concerning possible breaches of fiduciary duties by certain officers and directors at Heron Therapeutics.

Investors who purchased shares of Heron Therapeutics Inc (NASDAQ:HRTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain Heron Therapeutics officers and directors breached their fiduciary duties.
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) declined from $40.81 per share in late September 2015 to as low as $15.22 per share in March 2016.

On April 27, 2016, NASDAQ:HRTX shares closed at $21.41 per share.

Those who purchased NASDAQ:HRTX shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

John:
Related Post